Breast Cancer

Targeted therapy found to shrink tumor growth.

Side effects found to make it harder for patients to concentrate.

Researchers seek better targets for blocking events that lead to drug resistance.

Investigational drugs shut down critical genes and cancer cells responsible for tumor growth.

Adding a building block found in DNA could aid healthy cell production in cancer patients, study finds.

Treatment shows promising anti-tumor activity.

Perjeta (pertuzumab) is now approved for the neoadjuvant treatment of breast cancer.

FL118 could be effective in treating late stage cancers.

Researchers pinpoint method to reverse cancer cell resistance to chemotherapy.

Cimetidine has clinically important benefits in improving colon cancer survival and preclinical evidence shows that this benefit may extend to other types of cancer.

Preliminary evidence indicates that new treatment is both safe and effective.

Alcohol use is responsible for an estimated 3.5% of cancers in the United States, but affects the risk of developing some cancers more than others.

Increased number of patients moving away from breast conservation surgery in early stages of disease.

Combination therapy eliminates tumors in more than 70% of mice.

Drugs commonly used to treat osteoporosis may benefit patients with diseases like breast cancer.

Cost of medication causes financial burden for nearly two-thirds of patients.

Dispensing generic hormonal therapies instead of their brand-name counterparts increases breast cancer patients' life-saving medication adherence by 50%.

Nanotechnology and shortwave infrared light reveals small tumors and cardiovascular lesions deep inside body.

Researchers found significant improvements in overall survival and in disease-free survival in patients who received trastuzumab in addition to chemotherapy.

Adults aged 50 years or older who feel comfortable about aging are more likely to seek preventive health care services.

An estimated 6.9 million US adults aged 35 years and older had a combined 10.9 million self-reported smoking-attributable medical conditions in 2009.

Palbociclib provides first-line systemic treatment for women with advanced or metastatic breast cancer.

The FDA today granted priority review status to a breakthrough breast cancer drug developed by Pfizer Inc.

Brand name, patent-protected medications drive increasing costs.